Clinical Trials Browser

OTHER × Adjuvants, Pharmaceutic × 90 days × Clear all

NCT05296746 2026-05-14

RIBOLARIS

Phase 2 Active not recruiting

Breast Neoplasms

NCT02296684 2026-05-08

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Phase 2 Completed

67 enrolled 15 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms